Search research articles
Contact Us
Filters
Showing results (81-90 of 167) with videos related to
Page
of 17
Sort By:
Expert Review of Anticancer Therapy
|
May 1, 2015
Immune-related strategies driving immunotherapy in breast cancer treatment: a real clinical opportunity
Andrea Ravelli, James M Reuben, Francesco Lanza, et al.
Medical Oncology (Northwood, London, England)
|
July 31, 2015
Ibrutinib: from bench side to clinical implications
Davide Grisafi, Alessandra Maestro, Camilla Grumi, et al.
British Journal of Haematology
|
January 11, 2005
Darbepoetin alpha for the treatment of anaemia in low-intermediate risk myelodysplastic syndromes
Pellegrino Musto, Francesco Lanza, Enrico Balleari, et al.
Transplantation and Cellular Therapy
|
March 30, 2021
Low-Dose Cyclophosphamide versus Intermediate-High-Dose Cyclophosphamide versus Granulocyte Colony-Stimulating Factor Alone for Stem Cell Mobilization in Multiple Myeloma in the Era of Novel Agents: A Multicenter Retrospective Study
Beatrice Anna Zannetti, Francesco Saraceni, Claudia Cellini, et al.
Cytometry. Part B, Clinical Cytometry
|
November 6, 2008
A decreased positivity for CD90 on human mesenchymal stromal cells (MSCs) is associated with a loss of immunosuppressive activity by MSCs
Diana Campioni, Roberta Rizzo, Marina Stignani, et al.
Cytometry. Part B, Clinical Cytometry
|
June 24, 2015
Expression of the immunoglobulin superfamily cell membrane adhesion molecule Cd146 in acute leukemia
Francesco Cavazzini, Diana Campioni, Luisa Ferrari, et al.
American Journal of Hematology
|
August 22, 2024
Comparative clinical efficacy and safety of biosimilar ABP 959 and eculizumab reference product in patients with paroxysmal nocturnal hemoglobinuria
Austin Kulasekararaj, Francesco Lanza, Alexandros Arvanitakis, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 16, 2013
Evidence of epidermal growth factor receptor expression in uveal melanoma: inhibition of epidermal growth factor-mediated signalling by Gefitinib and Cetuximab triggered antibody-dependent cellular cytotoxicity
Adriana Amaro, Valentina Mirisola, Giovanna Angelini, et al.
Cytotherapy
|
November 16, 2010
Cell therapy medical tourism: time for action
Kurt C Gunter, Arthur L Caplan, Chris Mason, et al.
Cytotherapy
|
December 22, 2010
A simple method for identifying bone marrow mesenchymal stromal cells with a high immunosuppressive potential
Roberta Rizzo, Giacomo Lanzoni, Marina Stignani, et al.
Page
of 17
Search research articles
Search
Showing results (81-90 of 167) with videos related to
Sort By:
Page
of 17
Expert Review of Anticancer Therapy
|
May 1, 2015
Immune-related strategies driving immunotherapy in breast cancer treatment: a real clinical opportunity
Andrea Ravelli, James M Reuben, Francesco Lanza, et al.
Medical Oncology (Northwood, London, England)
|
July 31, 2015
Ibrutinib: from bench side to clinical implications
Davide Grisafi, Alessandra Maestro, Camilla Grumi, et al.
British Journal of Haematology
|
January 11, 2005
Darbepoetin alpha for the treatment of anaemia in low-intermediate risk myelodysplastic syndromes
Pellegrino Musto, Francesco Lanza, Enrico Balleari, et al.
Transplantation and Cellular Therapy
|
March 30, 2021
Low-Dose Cyclophosphamide versus Intermediate-High-Dose Cyclophosphamide versus Granulocyte Colony-Stimulating Factor Alone for Stem Cell Mobilization in Multiple Myeloma in the Era of Novel Agents: A Multicenter Retrospective Study
Beatrice Anna Zannetti, Francesco Saraceni, Claudia Cellini, et al.
Cytometry. Part B, Clinical Cytometry
|
November 6, 2008
A decreased positivity for CD90 on human mesenchymal stromal cells (MSCs) is associated with a loss of immunosuppressive activity by MSCs
Diana Campioni, Roberta Rizzo, Marina Stignani, et al.
Cytometry. Part B, Clinical Cytometry
|
June 24, 2015
Expression of the immunoglobulin superfamily cell membrane adhesion molecule Cd146 in acute leukemia
Francesco Cavazzini, Diana Campioni, Luisa Ferrari, et al.
American Journal of Hematology
|
August 22, 2024
Comparative clinical efficacy and safety of biosimilar ABP 959 and eculizumab reference product in patients with paroxysmal nocturnal hemoglobinuria
Austin Kulasekararaj, Francesco Lanza, Alexandros Arvanitakis, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 16, 2013
Evidence of epidermal growth factor receptor expression in uveal melanoma: inhibition of epidermal growth factor-mediated signalling by Gefitinib and Cetuximab triggered antibody-dependent cellular cytotoxicity
Adriana Amaro, Valentina Mirisola, Giovanna Angelini, et al.
Cytotherapy
|
November 16, 2010
Cell therapy medical tourism: time for action
Kurt C Gunter, Arthur L Caplan, Chris Mason, et al.
Cytotherapy
|
December 22, 2010
A simple method for identifying bone marrow mesenchymal stromal cells with a high immunosuppressive potential
Roberta Rizzo, Giacomo Lanzoni, Marina Stignani, et al.
Page
of 17